Accelerating the Shift to Downside Risk in Medicare Accountable Care Organizations: Effects on Clinical Quality and Costs among Older Patients
医疗保险责任医疗组织加速转向下行风险:对老年患者临床质量和成本的影响
基本信息
- 批准号:10625489
- 负责人:
- 金额:$ 4.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-30 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AccelerationAccountabilityAddressAdministratorAffectAmericanBenchmarkingCaringClinicalContractsCost ControlDataDropsEnd stage renal failureEvaluationFee-for-Service PlansHealthHealthcareHospitalsIncentivesInformation SystemsInterviewLocationMeasuresMedicareMedicare claimModelingMotivationOrganizational ModelsOutcomePathway interactionsPatient SelectionPatientsPerformancePhysiciansPolicy MakerPopulationPreventive servicePriceProcessProviderQuality of CareRewardsRiskSamplingSavingsStandardizationStructureTelephoneUnited States Centers for Medicare and Medicaid ServicesWorkaccountable care organizationbeneficiarycare coordinationcare costscare deliverycostcost shiftingdesignfallsfinancial incentivehealth care qualityhealth managementhigh riskimprovedinnovationinsightmindfulnessnext generationolder patientoptimismpaymentpopulation healthprogramssuccess
项目摘要
PROJECT SUMMARY
Older patients receive fragmented healthcare that is of variable quality and cost. To address this problem, the
Centers for Medicare & Medicaid Services (CMS) developed accountable care organizations (ACOs). ACOs
create incentives for providers to work together, while being mindful of their spending. Evaluations of the
Medicare Shared Savings Program (MSSP)—CMS’s largest ACO initiative—show that participating
organizations have improved care quality for older patients. Nonetheless, their costs remain high because they
do not have enough “skin in the game.” The majority of ACOs have contracts in which they share a small
percentage of the savings with Medicare when they reduce their annual costs below a benchmark but are not
penalized if they fall short (i.e., they have no downside risk). Without the financial threat of downside risk,
ACOs have less reason to innovate and increase efficiency. Thus, CMS announced “Pathways to Success” in
December 2018, requiring current MSSP ACOs to shift to downside risk in as little as one year. However,
shifting so quickly may be detrimental. The MSSP is voluntary, and many ACOs that have engaged in
meaningful care redesign may not be ready to take on the possibility of having to repay CMS millions and
leave the program instead. Indeed, 40% of ACOs facing contract renewal this July dropped out. Without the
potential for shared savings, exiting ACOs may divest their data systems and coordination capabilities needed
for population health management, which are costly to maintain. In turn, the ACOs’ patients may suffer lower
care quality and higher costs. The decision to stay in the MSSP may have unintended consequences, too.
ACOs may pursue cost-containment strategies like favorable patient selection. They may also limit their focus
to CMS-required metrics (at the expense of other clinically important ones). These moves would hurt older
patients who stand to gain the most from ACOs. In this context, we propose a combined qualitative and
quantitative study with three Specific Aims. 1) To examine decisions around MSSP participation and the
impact that these decisions have on an organization’s approach to care delivery after launch of
Pathways to Success. Using administrative data, we will purposefully sample 12 ACOs without downside risk
that faced contract renewal in 2019—six that renewed and six that did not. We will conduct semi-structured
phone interviews with key stakeholders to better understand what factors influenced their participation decision
and how their decision is affecting their efforts to improve care coordination and population health. 2) To
assess the effects of MSSP exit on clinical quality and costs among older patients. We will analyze
national Medicare claims (2008 to 2022) and identify MSSP-aligned fee-for-service beneficiaries. Among these
beneficiaries, we will then measure their healthcare quality and costs (based on CMS-required outcome and
process metrics and total price-standardized Medicare spending) before and after launch of Pathways to
Success. 3) To evaluate for unintended consequences on older patients from continued participation.
For ACOs identified in Aim 2 that remain in the MSSP, we will evaluate whether they take part in favorable
patient selection. We will also measure their organizational performance against CMS-required and non-
required outcome and process metrics before and after launch of Pathways to Success. Impact. Findings from
our study will provide policymakers with actionable insights as they incorporate downside risk into advanced
payment models and serve to inform ACO stakeholders who are considering organizational next steps.
项目摘要
老年患者接受分散的医疗保健,其质量和成本各不相同。为了解决这个问题,
医疗保险和医疗补助服务中心(CMS)开发了责任护理组织(ACO)。ACOs
鼓励提供者共同努力,同时注意他们的支出。的评价
医疗保险共享储蓄计划(MSSP)-CMS最大的ACO计划-表明,参与
组织提高了老年患者的护理质量。尽管如此,它们的成本仍然很高,
没有足够的“游戏中的皮肤”。大多数ACO都有合同,其中他们分享一小部分
当他们将年度成本降低到基准以下,但
如果它们达不到则受到惩罚(即,没有任何风险)。如果没有下行风险的财务威胁,
ACO没有太多理由去创新和提高效率。因此,CMS在2009年宣布了“成功之路”。
2018年12月,要求目前的MSSP ACO在短短一年内转向下行风险。然而,在这方面,
如此迅速的转变可能是有害的。MSSP是自愿的,许多从事
有意义的护理重新设计可能还没有准备好承担必须偿还CMS数百万美元的可能性,
而是离开程序。事实上,今年7月面临续约的ACO中有40%退出了。未经
共享节约的潜力,退出的ACO可能会剥离其数据系统和所需的协调能力
用于人口健康管理,维持成本高昂。反过来,ACO的病人可能会遭受更低的痛苦,
护理质量和更高的成本。留在MSSP的决定也可能产生意想不到的后果。
ACO可能会采取成本控制策略,如有利的患者选择。他们也可能会限制他们的注意力
CMS要求的指标(以牺牲其他临床重要指标为代价)。这些举动会伤害老年人
从助理文书主任那里获益最多的病人在这方面,我们提出了一个综合的定性和
定量研究有三个具体目标。1)审查有关MSSP参与的决定,
这些决定对一个组织在启动后提供护理的方法的影响
通往成功之路。使用行政数据,我们将有目的地抽样12个没有下行风险的ACO
在2019年面临合同续签-六个续签,六个没有。我们将进行半结构化
与主要利益相关者进行电话访谈,以更好地了解影响其参与决策的因素
以及他们的决定如何影响他们改善护理协调和人口健康的努力。2)到
评估MSSP退出对老年患者临床质量和成本的影响。我们将分析
国家医疗保险索赔(2008年至2022年),并确定与MSSP一致的按服务收费受益人。其中
受益人,然后我们将衡量他们的医疗质量和成本(基于CMS要求的结果,
流程指标和总价格标准化的医疗保险支出)之前和之后的路径,以
成功3)评价继续参与研究对老年患者造成的非预期后果。
对于目标2中确定的仍在MSSP中的ACO,我们将评估他们是否参与有利的
患者选择我们还将根据CMS要求和非CMS要求来衡量他们的组织绩效。
在启动“成功之路”之前和之后所需的成果和流程指标。冲击的结果
我们的研究将为政策制定者提供可操作的见解,因为他们将下行风险纳入先进的
支付模式,并为正在考虑组织下一步的ACO利益相关者提供信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRENT K. HOLLENBECK其他文献
BRENT K. HOLLENBECK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRENT K. HOLLENBECK', 18)}}的其他基金
Physician dispensing of oral specialty drugs for advanced prostate cancer and its implications for patients
医生对晚期前列腺癌口服专科药物的配药及其对患者的影响
- 批准号:
10862259 - 财政年份:2023
- 资助金额:
$ 4.57万 - 项目类别:
Physician dispensing of oral specialty drugs for advanced prostate cancer and its implications for patients
医生对晚期前列腺癌口服专科药物的配药及其对患者的影响
- 批准号:
10560826 - 财政年份:2023
- 资助金额:
$ 4.57万 - 项目类别:
Aligning financial incentives to promote rational use of active surveillance for prostate cancer
调整财政激励措施以促进前列腺癌主动监测的合理使用
- 批准号:
10416477 - 财政年份:2022
- 资助金额:
$ 4.57万 - 项目类别:
Aligning financial incentives to promote rational use of active surveillance for prostate cancer
调整财政激励措施以促进前列腺癌主动监测的合理使用
- 批准号:
10592422 - 财政年份:2022
- 资助金额:
$ 4.57万 - 项目类别:
Accelerating the Shift to Downside Risk in Medicare Accountable Care Organizations: Effects on Clinical Quality and Costs among Older Patients
医疗保险责任医疗组织加速转向下行风险:对老年患者临床质量和成本的影响
- 批准号:
10432116 - 财政年份:2020
- 资助金额:
$ 4.57万 - 项目类别:
Accelerating the Shift to Downside Risk in Medicare Accountable Care Organizations: Effects on Clinical Quality and Costs among Older Patients
医疗保险责任医疗组织加速转向下行风险:对老年患者临床质量和成本的影响
- 批准号:
10862329 - 财政年份:2020
- 资助金额:
$ 4.57万 - 项目类别:
Impact of urologist practice organization and health policy on prostate cancer treatment, overtreatment and spending
泌尿科医生执业组织和卫生政策对前列腺癌治疗、过度治疗和支出的影响
- 批准号:
10224611 - 财政年份:2017
- 资助金额:
$ 4.57万 - 项目类别:
Impact of urologist practice organization and health policy on prostate cancer treatment, overtreatment and spending
泌尿科医生执业组织和卫生政策对前列腺癌治疗、过度治疗和支出的影响
- 批准号:
9750134 - 财政年份:2017
- 资助金额:
$ 4.57万 - 项目类别:
Accountable care organizations and the diffusion of new surgical procedures
负责任的护理组织和新外科手术的传播
- 批准号:
9067196 - 财政年份:2015
- 资助金额:
$ 4.57万 - 项目类别:
Accountable care organizations and the diffusion of new surgical procedures
负责任的护理组织和新外科手术的传播
- 批准号:
8874423 - 财政年份:2015
- 资助金额:
$ 4.57万 - 项目类别:
相似海外基金
CRII: SaTC: Privacy vs. Accountability--Usable Deniability and Non-Repudiation for Encrypted Messaging Systems
CRII:SaTC:隐私与责任——加密消息系统的可用否认性和不可否认性
- 批准号:
2348181 - 财政年份:2024
- 资助金额:
$ 4.57万 - 项目类别:
Standard Grant
Attribution of Machine-generated Code for Accountability
机器生成代码的责任归属
- 批准号:
DP240102164 - 财政年份:2024
- 资助金额:
$ 4.57万 - 项目类别:
Discovery Projects
Global Governing Gaps and Accountability Traps for Solar Energy and Storage
太阳能和存储的全球治理差距和问责陷阱
- 批准号:
DP230103043 - 财政年份:2024
- 资助金额:
$ 4.57万 - 项目类别:
Discovery Projects
Collaborative Research: U.S. institutions after COVID-19: Trust, accountability, and public perceptions
合作研究:COVID-19 后的美国机构:信任、责任和公众看法
- 批准号:
2422394 - 财政年份:2024
- 资助金额:
$ 4.57万 - 项目类别:
Standard Grant
Collaborative Research: The Architecture of Accountability in 21st Century Latin America
合作研究:21 世纪拉丁美洲的问责架构
- 批准号:
2314749 - 财政年份:2023
- 资助金额:
$ 4.57万 - 项目类别:
Standard Grant
Ethical Industry 4.0: Embedding Legality, Integrity and Accountability in Digital Manufacturing Ecosystems
道德工业 4.0:将合法性、诚信和责任融入数字制造生态系统
- 批准号:
2412678 - 财政年份:2023
- 资助金额:
$ 4.57万 - 项目类别:
Standard Grant
Conference: Understanding Democracy, Elections, and Political Accountability
会议:了解民主、选举和政治责任
- 批准号:
2321010 - 财政年份:2023
- 资助金额:
$ 4.57万 - 项目类别:
Standard Grant
The Tipuna Project: Intergenerational Healing, Settler Accountability and Decolonising Participatory Action Research in Aotearoa
Tipuna 项目:新西兰的代际疗愈、定居者责任和非殖民化参与行动研究
- 批准号:
AH/X008223/1 - 财政年份:2023
- 资助金额:
$ 4.57万 - 项目类别:
Research Grant
Collaborative Research: SaTC: CORE: Small: Accountability for Central Bank Digital Currency
协作研究:SaTC:核心:小型:中央银行数字货币的责任
- 批准号:
2325477 - 财政年份:2023
- 资助金额:
$ 4.57万 - 项目类别:
Continuing Grant
DASS: A Multi-level Collaborative Design Framework for Cross-sovereignty Software Accountability
DASS:跨主权软件责任的多层次协作设计框架
- 批准号:
2317086 - 财政年份:2023
- 资助金额:
$ 4.57万 - 项目类别:
Standard Grant